Objectives-To assess the vascular involvement in labial salivary gland (LSG) from patients with rheumatoid vasculitis (RV). Methods-Forty seven patients with rheumatoid arthritis (RA) took part in a prospective study. Among them, 12 had proven RV. LSG biopsy was performxed after local anaesthesia.
Objectives-To assess the vascular involvement in labial salivary gland (LSG) from patients with rheumatoid vasculitis (RV). Methods-Forty seven patients with rheumatoid arthritis (RA) took part in a prospective study. Among them, 12 Rheumatoid vasculitis (RV) is an uncommon but extremely severe complication of rheumatoid arthritis (RA). The wide spectrum of cutaneous and systemic manifestations of vasculitis can sometimes explain the difficulties of the diagnosis. Estimates of the clinical incidence of RV in patients with RA have ranged from 0-5-15%.'1 2 However, biopsy specimen of skin or muscle in patients with RA The slides were analysed by two different pathologists and reviewed a third time in a masked fashion. On parafin sections, the analysis focussed on the evaluation of the infiltrate according to Chisholm's focus score (a focus is an aggregate of more than 50 round cells on four square millimetres). The assessment of immunopathological features of vascular damage was based on the examination of: (1) damage of blood vessels by fibrin deposition; (2) presence of infiltrate of leukocytoclastic polymorphonuclear leukocytes, or lymphocytes, or eosinophils; (3) presence of inflammatory granuloma and (4), on cryocut sections, the analysis was focussed on the presence of immune deposits on the vessel walls.
After a mean period of nine months after the onset of the treatment based on pulse of intravenous cyclophosphamide plus methylprednisolone given by intermittent bolus intravenous injection,7 five patients of group I with RV had a second LSG biopsy performed.
Statistical analysis was performed by the research department of medical statistics (CERIM). Non parametric t tests were used as well as Wilcoxon's and Fisher's procedures.
Results
There was no significant difference in demographic and clinical data between the two groups of patients with RA (table I) . However, most of the patients with RV (group I) had mild joint activity compared with the severe joint disease observed in group II patients who were admitted to hospital for evolutive RA. At the time of the study, there was no statistical difference in the treatment of RA (antiinflammatory drugs, corticosteroids, second line drugs). Four patients from group I and eight from group II were receiving methotrexate with a mean dose of 7x5 mg/week (p> 0-05).
No significant difference was observed between the two groups of patients with RA for all laboratory tests: erythrocyte sedimentation rate, C-reactive protein, fibrinogen, IgM rheumatoid factor, CH50, C3, C4. Mean value of IgM rheumatoid factor (laser nephelometric analysis, normal value <40 UIIml) was no different between the two groups due to one very high value in one of the patients from group II (7000 UIIml). Mean value and median of serum levels of immune complexes were higher in patients from group I but the difference was not statistically significant. von Willebrand factor antigen concentration in serum was not statistically elevated in patients with RV compared with patients of group II. However, von Willebrand factor antigen was strongly correlated with ESR, CRP, fibrinogen, rheumatoid factor and serum concentration of immunes complexes (p < 0 0 1).
In 1 1 of the 12 patients (92%) with proven RV (group I), immunopathological features of micro-vascular damage (size of the vessels involved = 50-80 ,u for capillaries, 100-200 ,u for veinules) were seen on the LSG biopsy. LSG biopsy is easy to perform and appears to be a relatively minor and safe procedure. None of our patients had pain, wound breakdown, or infection. There were no complaints of scarring of the area. Some authors consider LSG biopsy as a potentially traumatic procedure due to possible damage to branches of the mental nerve. However, these investigators excise six to eight of the minor salivary glands and close the wound with one or two black silk sutures. '5 Subclinical vasculitis is probably a more common and more widespread disease than is clinically apparent. In the present study, LSG biopsy was positive in 20% of patients with RA and no evidence ofvasculitis according to Scott and Bacon criteria.7 However, we cannot exclude such a diagnosis particularly in the two patients with symetrical peripheral neuropathy but no neuromuscular biopsy. LSG inflammatory vascular damage may reflect a systemic involvement of small size vessels which rarely causes serious internal organ dysfunction. The size of vessels involved and the absence of necrotising arteritis in LSG biopsy do not favour a worse prognostic significance. The absence of muscular arteries on LSG tissue and the early detection of microvascular damage on LSG biopsy might explain in our study the absence of necrotising arteritis (late stage of vasculitis). With a mean follow up of two years after diagnosis of RV, no recurrence was observed in patients from group I. With a same follow up of two years, no case of RV occurred in the seven patients (group II) with RA and positive LSG biopsy.
In conclusion, biopsy of LSG of the lower lip has now been used for many years, particularly in diagnosing sarcoidosis or amyloidosis and in the assessment of criteria for Sjogren's syndrome. The present study demonstrates that LSG biopsy seems to be a highly sensitive method for the diagnosis of immunopathological microvascular involvement and might suggest the diffusion of the vascular inflammatory process in RV. LSG biopsy can be done when vasculitis is suspected, particularly in the absence of skin lesion. However, the prognostic value of LSG involvement in RV remains unknown. Longitudinal studies in RA may give more information about the clinical and immunological relevance of the presence of vasculitis in LSG.
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